Registered Nurse in Chapmanville Wv, WV Accepting Medicare
8 Registered Nurse nurses found. Showing 1 - 8
 Melinda Duty, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 557 Main St, Chapmanville Wv, WV 25508 Phone: 304-855-4764 |
Billie Cullison, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 557 Main St, Chapmanville Wv, WV 25508 Phone: 304-855-4764 |
 Richard Nelson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 557 Main St, Chapmanville Wv, WV 25508 Phone: 304-855-4764 |
Bailey Cooper, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 557 Main St, Chapmanville Wv, WV 25508 Phone: 304-855-4764 |
Cynthia Williamson, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 557 Main St, Chapmanville Wv, WV 25508 Phone: 304-855-4764 |
Ashley Miller, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 557 Main St, Chapmanville Wv, WV 25508 Phone: 304-855-4764 |
Thomas Blair, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 557 Main St, Chapmanville Wv, WV 25508 Phone: 304-855-4764 |
Stephanie Hurley, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 557 Main St, Chapmanville Wv, WV 25508 Phone: 304-855-4764 |
News Archive
Titan Pharmaceuticals files registration statement on Form 10 with SEC
Titan Pharmaceuticals, Inc. (Pink Sheets: TTNP) today announced that on January 14, 2010 it filed a registration statement on Form 10 with the U.S. Securities and Exchange Commission ("SEC") in order to register its common stock under the Securities Exchange Act of 1934 ("Exchange Act").
Cannabinoids may block development of PTSD symptoms after traumatic experience
Cannabinoids (marijuana) administration after experiencing a traumatic event blocks the development of post-traumatic stress disorder (PTSD)-like symptoms in rats, according to a new study conducted at the University of Haifa and published in the journal Neuropsychopharmacology.
Mylan Pharmaceuticals receives FDA approval for Bupropion HCl ER Tablets
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Bupropion Hydrochloride Extended-release Tablets USP, 150 mg, the generic version of GlaxoSmithKline's smoking cessation aid, Zyban.
ZIOPHARM Oncology begins public offering of common stock
ZIOPHARM Oncology, Inc. announced today that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in a public offering. JMP Securities LLC and Rodman & Renshaw, LLC are acting as co-lead managers for the offering.
New rapid diagnostic test for multi-resistance to broad-spectrum antibiotics
A rapid diagnostic test for multi-resistance to broad-spectrum antibiotics has just been developed at the University of Fribourg. Prof Patrice Nordmann and Dr Laurent Poirel of the Medical and Molecular Microbiology Unit have been collaborating with Unit 914 of the National Institute of Health and Medical Research (INSERM) in Paris, of which Patrice Nordmann is also Director.
› Verified 6 days ago